Medtech is a federally regulated industry, which means changes in public policy can have a profound and immediate impact on your company. For 25 years, MassMEDIC has led the way in advocating for sound public policy that doesn’t unintentionally hurt medical innovation. As a result, we have developed close relationship with our congressional delegation and state leaders to make sure they understand our industry and its needs. This approach has helped our industry weather many difficult moments.
During the COVID-19 crisis, for example, MassMEDIC helped ensure that medtech workers were deemed essential throughout the state lockdowns. We also were able to make sure our manufacturing workers got priority access to vaccination. In addition, we played an integral role in repealing the 2.3% medical device excise tax, tamping down the onerous Massachusetts gift ban, and helped lead the way to a more predictable FDA.